The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The Scheme seeks to generate long-term capital growth by investing in a concentrated portfolio of equity & equity related instruments of up to 25 companies across market capitalization.
The scheme aims to invest a greater proportion of assets in overseas mutual funds investing in globally emerging markets funds. T. Rowe Price SICAV, (TGEMF) which is a Luxembourg domiciled Fund, has been identified by Kotak Mutual Fund as the portfolio for the purpose of Kotak Global Emerging Market Fund.
The scheme aims to generate capital appreciation by investing in a concentrated portfolio of large cap focused equity and equity related securities of upto 30 companies.
The fund would predominantly invest in units of BlackRock Global Funds - World Mining Fund. In addition to this, a significant part of its corpus would be invested in units of other similar overseas mutual fund schemes.
The scheme seeks to provide returns that closely correspond to returns provided by Canara Robeco Gold Exchange Traded Fund.
The scheme seeks to invest in companies which are constituents of NIFTY 50 Equal Weight Index (underlying Index) in the same proportion as in the index and seeks to generate returns that are commensurate (before fees and expenses) with the performance of the underlying Index.
The scheme aims at achieving long term growth of capital along with income tax relief for investment. At least 80% of the funds will be invested in equity instruments.
The objective of this scheme is to generate returns that correspond closely to the returns generated by IDBI Gold Exchange Traded Fund.
The scheme aims to generate capital appreciation by investing in a diversified portfolio of equity and equity related securities of large cap companies.